Driscoll, C., Handa, N., Hao, Y., Alshalalfa, M., Hakansson, A. K., Proudfoot, J. A., Davicioni, E., Ross, A., Catalona, W., Cooperberg, M. R., Schaeffer, E. M., Kundu, S. D. (2025). Tumor necrosis factor alpha signaling activity and NCCN risk, adverse pathology, and progression during active surveillance in prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.415